咽喉反流性疾病的影响因素及治疗效果分析

doi:10.6040/j.issn.1673-3770.0.2018.472

摘要/Abstract

摘要： 目的

了解咽喉反流性疾病(LPRD)的影响因素和治疗效果。

方法

选取2018年2～8月门诊收治的112例咽喉疾病患者，通过反流症状指数评分量表（RSI）和反流体征评分量表（RFI）诊断。采用视觉模拟评分法（VSA）评分。采用饮食和生活习惯调整(一级治疗)，质子泵抑制剂(PPI)和胃肠动力药治疗（二级治疗）4~6周。对年龄、性别、职业、饮食、受凉、压力、情绪、胃疾病史等进行单因素分析和二元Logistic回归分析，比较治疗前后的RSI和VSA评分。

结果

112例慢性咽喉疾病患者随访率90%，LPRD 83例，占门诊慢性咽喉疾病患者的83%。单因素分析结果显示，饮食（χ2=4.123, P<0.05）、胃疾病史（χ2=14.912, P<0.01）差异有统计学意义；而性别(χ2=0.681, P>0.05)、年龄(χ2=0.681, P>0.05)、职业(χ2=0.024，P>0.05)、受凉(χ2=0.649，P>0.05)、压力(χ2=1.197, P>0.05)、情绪(χ2=0.940，P>0.05)差异无统计学意义。二元Logistic回归分析结果显示，饮食（χ2=4.480，P<0.05）、胃疾病史（χ2=7.792, P<0.01）是LPRD的影响因素。临床治疗显效50.61%(41例)、有效37.01%（30例）、无效12.34%（10例）。轻症一级治疗前后VAS(t=9.41, P<0.01)和RSI(t=10.59, P<0.01)，轻症一二级联合治疗VAS(t=20.59, P<0.01)和RSI(t=22.03, P<0.01)，重症一二级联合治疗VAS(t=6.82，P<0.05)和RSI(t=4.8, P<0.05)评分差异均有统计学意义。

结论

饮食、胃疾病史是LPRD的影响因素，调整饮食和生活习惯联合PPI和胃肠动力剂治疗LPRD效果较好。

关键词: 咽喉反流性疾病, 危险因素, 饮食, 胃疾病, 治疗结局

Abstract: Objective

To understand the influencing factor and therapeutic effects of laryngopharyngeal reflux disease(LPRD).

Methods

A total of 112 patients with chronic laryngopharyngeal disease were enrolled in this study in the period from February 2018 to August 2018. The patients were diagnosed with LPRD using the reflux symptom index(RSI), the reflux finding score (RFS), and the visual analogue scale(VAS) score. The patients with LPRD were treaded with modifications in diet and living habits(primary treatment) and. with proton pump inhibitors (PPIs) and prokinetic agents(secondary treatment) for 4-6weeks. Simultaneously, the factors of age, sex, occupation, diet, cold, stress, mood and gastric history were analyzed by single-factor and binary logistic regression analysis. In addition, RSI and VAS score before and after treatment was analyzed.

Results

Among the 112 patients with chronic laryngopharyngeal disease, the follow-up rate was 90%. Among patients with LPRD, chronic laryngopharyngeal disease was diagnosed in 83% (83 cases).Single-factor analysis showed that diet（χ2=4.124, P<0.05）and history of stomach problems (χ2=14.912, P<0.01)were statistically significant, whereas sex(χ2=0.681, P>0.05), age(χ2=0.681, P>0.05), occupation(χ2=0.024, P>0.05), cold(χ2=0.649, P>0.05), stress(χ2=1.197, P>0.05), and mood(χ2=0.940, P>0.05) were not statistically significant. Binary logistic regression analysis showed that diet（x2=4.480, P<0.05） and history of stomach（χ2=7.792, P<0.01） were the influencing factors of LPRD. The clinical efficacy of treatment was significant in 50.61% (41 cases), effective in 37.07%(30 cases） and ineffective in 12.34%(10 cases). The differences of VAS(t=9.41, P<0.01) and RSI(t=10.59, P<0.01)score were statistically significant before and after primary treatment for mild LPRD. The differences of VAS(t=20.59, P<0.01) and RSI(t=22.03,P<0.01)score were statistically significant before and after primary combined with secondary treatment for mild LPRD. The differences of VAS(t=6.82，P<0.05) and RSI(t=4.8, P<0.05) score were statistically significant before and after primary combined with secondary treatment for severe LPRD.

Conclusion

LPRD was a common disease in the otorhinolaryngology clinic. Diet and history of stomach problems were the influencing factors of LPRD. It was treated effectively by adjusting diet and living habits combined with PPI and prokinetic agents.

Key words: Laryngopharyngeal reflux disease, Risk factors, Diet, Stomach diseases, Treatment outcome

中图分类号:

R767

郎永耀,杨云,刘晴,徐林弟,林子萍. 咽喉反流性疾病的影响因素及治疗效果分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 119-123.

Yongyao LANG,Yun YANG,Qing LIU,Lindi XU,Ziping LIN. Analysis of influencing factors and observation of therapeutic effects in patients with laryngopharyngeal reflux disease[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 119-123.

图/表 3

表1

表2

咽喉疾病100例单因素分析"

因素	例数	LPRD [n(%)]	$χ 2$	P
性别			0.681	0.411
男	63	52（62.7）
女	37	31（37.3）
年龄(岁)			0.681	0.441
≤45	47	40（48.2）
>45	53	43（51.8）
职业			0.024	0.877
脑力	13	12(14.4)
体力	39	31(37.3)
自由职业	48	40(48.2)
饮食			4.123	0.045
嗜酒、暴饮暴食	48	44(53.0)
无	52	39(47.0)
受凉			0.649	0.422
有	27	24(28.9)
无	73	59(71.1)
压力			1.197	0.277
有	21	16(19.3)
无	79	67(80.7)
焦虑忧郁状态			0.940	0.335
有	14	13(15.7)
无	86	70(84.3)
胃疾病史			14.912	0.000
有	54	52(62.7)
无	46	31(37.3)

表2

表3

参考文献 10

1	韩德民, T. SataloffRobert , 徐文. 嗓音医学[M]. 2版. 北京: 人民卫生出版社, 2017:194-200.
2	李进让，肖水芳，李湘平，等.咽喉反流性疾病诊断与治疗专家共识（2015年）[J]. 中华耳鼻咽喉头颈外科杂志，2016, 51（5）：324-326.doi：10.3760/cma.j.issn.1673-0860.2016.05.002. doi: 10.3760/cma.j.issn.1673-0860.2016.05.002
	LIJinrang,XIAOShuifang,LIXiangping， et al. Experts consensus on diagnosis and treatment of Laryngopharyngeal ruflux disease (2015)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51 (5):324-326.doi：10.3760/cma.j.issn.1673-0860.2016.05.002. doi: 10.3760/cma.j.issn.1673-0860.2016.05.002
3	BacciuA, MercanteG, IngegnoliA, et al. Effects of gastroesophageal reflux disease in laryngeal carcinoma[J]. Clin Otolaryngol Allied Sci, 2004, 29(5): 545-548. doi:10.1111/j.1365-2273.2004.00851.x. doi: 10.1111/j.1365-2273.2004.00851.x
4	CohenJT, BachKK, PostmaGN, et al. Clinical manifestations of laryngopharyngeal reflux[J]. Ear Nose Throat J, 2002, 81(9 Suppl2): 19-23.PMID: 12353427.
5	李湘平, 黄柞峰, 吴婷, 等. 咽喉反流在声带白斑及早期声带癌发病中的初步观察[J]. 中华耳鼻咽喉头颈外科杂志, 2014, 49(5): 362-367. doi:10.3760/cma.j.issn.1673-0860.2014.05.003. doi: 10.3760/cma.j.issn.1673-0860.2014.05.003
	LIXiangping, HUANGZuofeng, WUTing, et al. Role of laryngopharyngeal reflux on the pathogenesis of vocal cord leukoplakia and early glottic cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2014, 49(5): 362-367. doi:10.3760/cma.j.issn.1673-0860.2014.05.003. doi: 10.3760/cma.j.issn.1673-0860.2014.05.003
6	邓月琴, 王路, 陈怀宏, 等. 胃蛋白酶在舌扁桃体组织中的表达及临床意义[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(7): 525-530. doi:10.3760/cma.j.issn.1673-0860.2017.07.009. doi: 10.3760/cma.j.issn.1673-0860.2017.07.009
	DENGYueqin, WANGLu, CHENHuaihong, et al. Expression and significance of pepsin in lingual tonsil hypertrophy[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2017, 52(7): 525-530. doi:10.3760/cma.j.issn.1673-0860.2017.07.009. doi: 10.3760/cma.j.issn.1673-0860.2017.07.009
7	李进让.咽喉反流性疾病的规范化诊断与治疗[J]. 中国耳鼻咽喉头颈外科, 2015, 22（9）：435-437. doi:10.16066/j.1672-7002.2015.09.001. doi: 10.16066/j.1672-7002.2015.09.001
	LIJinrang. The benchmarking diagnosis and therapy of laryngopharyngeal reflux disease[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2015, 22(9): 435-437. doi:10.16066/j.1672-7002.2015.09.001. doi: 10.16066/j.1672-7002.2015.09.001
8	李可亮, 李进让. 质子泵抑制剂联合胃肠动力药治疗咽喉反流性疾病的Meta分析[J]. 中国耳鼻咽喉头颈外科, 2014, 21(7): 367-371.
	LIKeliang, LIJinrang. Meta analysis of proton pump inhibitor and proton pump inhibitor with prokinetic agents in the treatment of laryngopharyngeal reflux disease[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2014, 21(7): 367-371.
9	陈寻，杨云，陈智斌.喉咽反流性疾病的临床治疗研究[J]. 山东大学耳鼻咽喉眼学报，2016 , 30（1）: 67-69, 73. doi:10.6040/j.issn.1673-3770.0.2015.433. doi: 10.6040/j.issn.1673-3770.0.2015.433
	CHENXun,YANGYun,CHENZhibin. Clinical treaterment of laryngeal and pharyngeal reflux disease[J]. Journal of Otorhinolaryngology and Ophthalmology of Shandong University, 2016，30（1）67-69, 73. doi:10.6040/j.issn.1673-3770.0.2015.433. doi: 10.6040/j.issn.1673-3770.0.2015.433
10	孙娜，陈晓平.咽喉反流性疾病与咽喉科疾病[J]. 山东大学耳鼻咽喉眼学报，2016，30（6）: 85-89. doi:10.6040/j.issn.1673-3770.0.2016.213. doi: 10.6040/j.issn.1673-3770.0.2016.213
	SUNNa, CHENXiaoping. Laryngopharyngeal diseases[J]. Journal of Otorhinolaryngology and Ophthalmology of Shandong University,2016，30（6）85-89. doi:10.6040/j.issn.1673-3770.0.2016.213. doi: 10.6040/j.issn.1673-3770.0.2016.213

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

组别	一级治疗（轻症）		一二级治疗（轻症）		一二级治疗（重症）
组别	VAS评分	RIS评分	VAS评分	RIS评分	VAS评分	RIS评分
治疗前	4.77±0.97	14.68±1.28	8.39±0.63	14.45±2.05	8.00±1.00	17.22±4.26
治疗后	1.69±1.61	5.50±3.77	2.94±1.80	3.62±3.07	5.11±1.90	7.55±3.46
t	9.41	10.59	20.59	22.03	6.82	4.8
P	<0.01	<0.01	<0.01	<0.01	<0.05	<0.05

指标	β	SE	Wals χ²	P OR	（95%CI）
饮食	1.510	0.713	4.480	0.034 4.526	（1.421~41.807）
胃疾病史	2.319	0.831	7.792	0.005 10.165	（2.595~87.617）

[1]	罗通勇,杨华清,岳胜清,贾全凡,袁龙. 帕尼单抗和紫杉醇一线治疗复发或转移性头颈肿瘤Ⅱ期患者效果观察[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 71-75.
[2]	张贵阳,黄河,冼志,张汉文,谢桂彩. 粉尘螨滴剂舌下含服免疫治疗对不同年龄段变应性鼻炎患者的临床效果评估[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 60-65.
[3]	钟晓声,杨海弟,郑亿庆. 突发性聋伴耳鸣的治疗与转归[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 43-46.
[4]	申宇鹏,宋琦,李晓明. 喉癌前病变的病因、分子机制和处理策略[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 25-30.
[5]	刘鸣. 早期声门癌的内镜治疗[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 6-9.
[6]	黄河,欧阳晖. 下咽癌共病食管癌的高危因素及预后分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 82-86.
[7]	王登元,陈智斌,王杪琳. 伴发梅尼埃病的良性阵发性位置性眩晕的临床特点[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 61-65.
[8]	王登元, 陈智斌, 邢光前. 耳内镜微创术——耳科手术的新途径[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 27-30.
[9]	姜秀颖,李元彬. 后房型人工晶体脱位的临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 105-110.
[10]	崔乐,关凯,李丽莎,李俊达,王子熹,徐迎阳,王良录,尹佳. 蜜蜂研究人群中蜂毒过敏患病率及相关危险因素分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 63-66.
[11]	王刚,吴玮,王磊,刘红丹,徐小杭,徐冰心,丁瑞英,周莹,韩浩伦,龚敬,李保卫,孙喆喆. Ryan指数与反流症状指数量表、反流体征量表在咽喉反流性疾病诊断中的相关性分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 48-52.
[12]	沈翎,林宗通,林兴,杨中婕. 儿童阻塞性睡眠呼吸暂停低通气综合征危险因素的[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 25-29.
[13]	刘哲综述, 滕博,文连姬审校. 室内空气污染物及饮食结构对变应性疾病的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 96-102.
[14]	王国强, 赵春红, 霍红, 龚志云, 宋伟伟, 严丽霞, 李雪华, 王伟丽. 早产儿听力筛查结果及其听力障碍危险因素[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 7-10.
[15]	葛星, 吕玲双, 潘铭, 时巧梅, 许建峰, 林友结, 孙雅慧, 神平. 打鼾相关流行病学现状及其影响因素调查研究——以徐州地区为例[J]. 山东大学耳鼻喉眼学报, 2014, 28(5): 10-13.